Welcome to our dedicated page for Fidelity National Financial In SEC filings (Ticker: FNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fidelity National Financial, Inc. (NYSE: FNF) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. FNF is incorporated in Nevada and its common stock is registered under Section 12(b) of the Securities Exchange Act of 1934, trading on the New York Stock Exchange under the symbol FNF. Through its filings, investors can review information about the company’s title insurance and transaction services operations, its majority-owned subsidiary F&G Annuities & Life, Inc. (NYSE: FG), and its capital allocation decisions.
FNF submits Form 8-K current reports to disclose material events, such as quarterly earnings releases and special stock distributions. For example, the company files 8-Ks to furnish earnings releases for its Title and F&G segments, and to describe the approval and terms of a special stock distribution of F&G common stock to FNF shareholders, including the distribution date, record date, distribution ratio and expected U.S. federal income tax treatment.
Other SEC reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, provide additional detail on segment performance, risk factors and accounting policies, while proxy materials can address governance matters and board actions. Investors interested in ownership and trading activity by FNF insiders can review Form 4 filings, which report changes in beneficial ownership of FNF equity securities by directors, officers and other insiders.
On this page, AI-powered tools can help summarize lengthy filings, highlight key items such as segment results, special distributions and non-GAAP measures, and make it easier to identify the sections most relevant to title insurance operations and F&G’s insurance solutions business. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, 10-Ks and other forms are available as they are filed, while AI-generated overviews can assist users in understanding the implications of these documents without reading every page in detail.
Fidelity National Financial (FNF) reported an insider equity award. A director acquired 4,870 shares of common stock on November 10, 2025 at $0, reflecting a grant of restricted stock.
The award vests in three equal annual installments beginning on November 10, 2026. Following the grant, the director directly owns 41,620 shares of FNF common stock.
Fidelity National Financial (FNF) disclosed an insider equity award. A director acquired 4,870 shares of common stock on 11/10/2025 at $0 as a grant of restricted stock, which vests in three equal annual installments beginning on November 10, 2026.
Following this grant, the director beneficially owns 282,675 shares, reported as directly held.
Fidelity National Financial (FNF) reported an insider equity award. A company director received a grant of 4,870 shares of restricted common stock on November 10, 2025, at a stated price of $0.
The award vests in three equal annual installments beginning on November 10, 2026. Following this transaction, the reporting person beneficially owned 349,511.6 shares, held directly.
Fidelity National Financial (FNF) reported a director equity grant. On 11/10/2025, the director received 4,870 shares of common stock at $0 as restricted stock, vesting in three equal annual installments beginning on 11/10/2026. Following the grant, the director beneficially owned 19,186 shares, held directly. This reflects routine equity compensation disclosed on a Form 4.
Fidelity National Financial (FNF) reported an insider equity grant. A director acquired 4,870 shares of common stock on 11/10/2025 as a restricted stock award priced at $0. Following the transaction, the director beneficially owns 149,340.553 shares, held directly.
The award vests in three equal annual installments beginning on November 10, 2026.
Fidelity National Financial (FNF)acquired 29,218 shares of restricted common stock at $0. The award vests in three equal annual installments beginning 11/10/2026, subject to performance criteria in the award agreement.
Following the grant, directly held common stock was 195,026.988 shares. Indirect holdings included 2,606.07 shares in a 401(k) account, 473 shares in an IRA, and 74,898 shares in a trust.
Fidelity National Financial (FNF) reported an insider equity grant on a Form 4. The reporting person, a Director and Executive Vice‑Chairman, acquired 55,653 shares of restricted common stock on 11/10/2025 at $0 under transaction code A.
The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following the transaction, beneficial holdings were 200,387.2675 shares direct, plus 565.2 indirect via a 401(k) account and 2,150,955 indirect via the Quirk 2002 Trust.
Fidelity National Financial (FNF) reported an insider equity grant by its EVP & Chief Financial Officer. On 11/10/2025, the officer acquired 31,044 shares of common stock at $0, reflecting a grant of restricted stock. These shares vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.
Following the transaction, beneficial ownership stands at 140,327.3516 shares direct, plus indirect holdings of 272,759 shares via the Park Family Trust and 3.11 shares in a 401(k) account.
Fidelity National Financial (FNF) reported an insider equity award. On November 10, 2025, the Chief Executive Officer acquired 100,000 shares of common stock at $0 via a restricted stock grant. These shares vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.
After the grant, the reporting person held 577,001.6534 shares directly and 14,585.324 shares indirectly through the Michael J. Nolan Trust.
Fidelity National Financial (FNF) reported an insider equity award. On 11/10/2025, an Executive Vice President received 27,827 shares of restricted common stock at a price of $0.
The award vests in three equal annual installments beginning November 10, 2026, and is subject to performance criteria outlined in the award agreement. Following this grant, the reporting person beneficially owned 307,404.6147 shares, held directly.